Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6‐month results of a prospective controlled trial
Open Access
- 22 June 2006
- journal article
- research article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 84 (5) , 624-630
Abstract
: Purpose: To evaluate prospectively the efficacy and safety of one intravitreal injection of 4 mg triamcinolone acetonide for refractory diffuse diabetic macular edema.Methods: Seventeen patients with bilateral diabetic macular edema unresponsive to laser photocoagulation. In all patients, one eye was injected, and the other served as a control. The intervention consisted in intravitreal injection of 4 mg triamcinolone acetonide. The main outcome measure was central macular thickness (CMT) at 4, 12 and 24 weeks, measured by Optical Coherence Tomography. Secondary outcomes were Early Treatment Diabetic Rentinopathy Study (ETDRS) scores, intraocular pressure and cataract progression.Results: Before injection, mean ± SD CMT was 566.4 ± 182.4 μm in injected eyes. Four, 12, and 24 weeks after injection, it was 228.4 ± 47.5 μm, 210.9 ± 87.2 μm and 358.5 ± 160.5 μm respectively. CMT was significantly lower in injected eyes vs. control eyes except 24 weeks after injection because of a recurrence of macular edema in 9/17 injected eyes. Mean ± SD gain in ETDRS score was significantly better in injected eyes vs. control eyes 4, 12 and 24 weeks after TA injection. In 9 of the 17 injected eyes, intraocular pressure exceeded 24 mmHg and was controlled by topical medication.Conclusion: In the short‐term, intravitreal injection of triamcinolone effectively reduces macular thickening due to diffuse diabetic macular edema and improves visual acuity in most cases. The long‐term effect of this treatment and predictive factors of visual recovery remain to be elucidated.Keywords
This publication has 35 references indexed in Scilit:
- Pharmacokinetic–Pharmacodynamic Modeling of the Effect of Triamcinolone Acetonide on Central Macular Thickness in Patients with Diabetic Macular EdemaInvestigative Ophthalmology & Visual Science, 2004
- Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology, 2003
- Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1Journal of Biological Chemistry, 1999
- Induction of Vascular Endothelial Growth Factor by Platelet-Activating Factor and Platelet-Derived Growth Factor is Downregulated by CorticosteroidsAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- The Lens Opacities Classification System IIIArchives of Ophthalmology (1950), 1993
- Modified Grid Laser Photocoagulation for Diffuse Diabetic Macular EdemaOphthalmology, 1991
- Photocoagulation for Diabetic Macular EdemaArchives of Ophthalmology (1950), 1985
- Visual Impairment in DiabetesOphthalmology, 1984
- The Reproducibility of the Intraocular Pressure Response to DexamethasoneAmerican Journal of Ophthalmology, 1975
- Twin Study on Ocular Pressure after Topical DexamethasoneAmerican Journal of Ophthalmology, 1973